Literature DB >> 24628015

Regulation of ACh release from guinea pig bladder urothelial cells: potential role in bladder filling sensations.

L M McLatchie1, J S Young, C H Fry.   

Abstract

BACKGROUND AND
PURPOSE: The aim of this study was to quantify and characterize the mechanism of non-neuronal ACh release from bladder urothelial cells and to determine if urothelial cells could be a site of action of anti-muscarinic drugs. EXPERIMENTAL APPROACH: A novel technique was developed whereby ACh could be measured from freshly isolated guinea pig urothelial cells in suspension following mechanical stimulation. Various agents were used to manipulate possible ACh release pathways in turn and to study the effects of muscarinic receptor activation and inhibition on urothelial ATP release. KEY
RESULTS: Minimal mechanical stimulus achieved full ACh release, indicating a small dynamic range and possible all-or-none signal. ACh release involved a mechanism dependent on the anion channel CFTR and intracellular calcium concentration, but was independent of extracellular calcium, vesicular trafficking, connexins or pannexins, organic cation transporters and was not affected by botulinum-A toxin. Stimulating ACh receptors increased ATP production and antagonizing them reduced ATP release, suggesting a link between ACh and ATP release. CONCLUSIONS AND IMPLICATIONS: These results suggest that release of non-neuronal ACh from the urothelium is large enough and well located to act as a modulator of ATP release. It is hypothesized that this pathway may contribute to the actions of anti-muscarinic drugs in reducing the symptoms of lower urinary tract syndromes. Additionally the involvement of CFTR in ACh release suggests an exciting new direction for the treatment of these conditions.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  ATP; CFTR; anti-muscarinic agents; non-neuronal ACh; urinary bladder; urothelial cells

Mesh:

Substances:

Year:  2014        PMID: 24628015      PMCID: PMC4105928          DOI: 10.1111/bph.12682

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Structure and Function of Renal Organic Cation Transporters.

Authors:  Hermann Koepsell; Andreas Busch; Valentin Gorboulev; Petra Arndt
Journal:  News Physiol Sci       Date:  1998-02

2.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

Authors:  Tonghui Ma; Jay R Thiagarajah; Hong Yang; Nitin D Sonawane; Chiara Folli; Luis J V Galietta; A S Verkman
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action.

Authors:  Ana Coelho; Francisco Cruz; Célia D Cruz; António Avelino
Journal:  Eur Urol       Date:  2012-02-01       Impact factor: 20.096

Review 4.  Antimuscarinic mechanisms and the overactive detrusor: an update.

Authors:  Karl-Erik Andersson
Journal:  Eur Urol       Date:  2010-12-08       Impact factor: 20.096

Review 5.  Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?

Authors:  Steven M Finney; Karl-Erik Andersson; James I Gillespie; Laurence H Stewart
Journal:  BJU Int       Date:  2006-09       Impact factor: 5.588

6.  CFTR-independent ATP release from epithelial cells triggered by mechanical stimuli.

Authors:  R Grygorczyk; J W Hanrahan
Journal:  Am J Physiol       Date:  1997-03

7.  Acetylcholine and molecular components of its synthesis and release machinery in the urothelium.

Authors:  Katrin S Lips; Julia Wunsch; Shirin Zarghooni; Thomas Bschleipfer; Konstantin Schukowski; Wolfgang Weidner; Ignaz Wessler; Ulrich Schwantes; Hermann Koepsell; Wolfgang Kummer
Journal:  Eur Urol       Date:  2006-10-27       Impact factor: 20.096

8.  Release of ATP from retinal pigment epithelial cells involves both CFTR and vesicular transport.

Authors:  David Reigada; Claire H Mitchell
Journal:  Am J Physiol Cell Physiol       Date:  2004-09-15       Impact factor: 4.249

9.  Failure of the cystic fibrosis transmembrane conductance regulator to conduct ATP.

Authors:  M M Reddy; P M Quinton; C Haws; J J Wine; R Grygorczyk; J A Tabcharani; J W Hanrahan; K L Gunderson; R R Kopito
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

Review 10.  Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder.

Authors:  F Haab; L Stewart; P Dwyer
Journal:  Eur Urol       Date:  2004-04       Impact factor: 20.096

View more
  11 in total

Review 1.  Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium.

Authors:  Donna Sellers; Russ Chess-Williams; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

2.  Enhanced urothelial ATP release and contraction following intravesical treatment with the cytotoxic drug, doxorubicin.

Authors:  Sung-Hyun Kang; Catherine McDermott; Stefanie Farr; Russ Chess-Williams
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-17       Impact factor: 3.000

Review 3.  The Emerging Role of Inflammasomes as Central Mediators in Inflammatory Bladder Pathology.

Authors:  Brian M Inouye; Francis M Hughes; Stephanie J Sexton; J Todd Purves
Journal:  Curr Urol       Date:  2017-12-30

4.  Cystic fibrosis transmembrane conductance regulator modulates enteric cholinergic activities and is abnormally expressed in the enteric ganglia of patients with slow transit constipation.

Authors:  Ka Ming Yeh; Olle Johansson; Huy Le; Karan Rao; Irit Markus; Dayashan Shevy Perera; David Zachary Lubowski; Denis Warwick King; Li Zhang; Hongzhuan Chen; Lu Liu
Journal:  J Gastroenterol       Date:  2019-08-07       Impact factor: 7.527

Review 5.  The Role of the Mucosa in Normal and Abnormal Bladder Function.

Authors:  Christopher H Fry; Bahareh Vahabi
Journal:  Basic Clin Pharmacol Toxicol       Date:  2016-08-05       Impact factor: 4.080

6.  NKA enhances bladder-afferent mechanosensitivity via urothelial and detrusor activation.

Authors:  Luke Grundy; Russ Chess-Williams; Stuart M Brierley; Kylie Mills; Kate H Moore; Kylie Mansfield; Roselyn Rose'Meyer; Donna Sellers; David Grundy
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-13

7.  Acetylcholine released by endothelial cells facilitates flow-mediated dilatation.

Authors:  Calum Wilson; Matthew D Lee; John G McCarron
Journal:  J Physiol       Date:  2016-12-15       Impact factor: 5.182

8.  TRPV1 enhances the afferent response to P2X receptor activation in the mouse urinary bladder.

Authors:  Luke Grundy; Donna M Daly; Christopher Chapple; David Grundy; Russ Chess-Williams
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

9.  Purinergic signalling in the urinary bladder - When function becomes dysfunction.

Authors:  Christopher H Fry; Karen D McCloskey
Journal:  Auton Neurosci       Date:  2021-07-17       Impact factor: 2.355

Review 10.  Signalling molecules in the urothelium.

Authors:  Michael Winder; Gunnar Tobin; Daša Zupančič; Rok Romih
Journal:  Biomed Res Int       Date:  2014-08-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.